Skin cancers

Australian dermatologists use ‘Trojan horse’ virus to deliver interferon within BCCs

Intralesional injections of a genetically modified adenovirus carrying human genes which code for gamma interferon are showing promise as a treatment for multiple BCCs. Dermatologist and principal investigator Dr Greg Siller, from Central Brisbane Dermatology, leads a phase 2 study of the adenovirus combined with the hedgehog pathway inhibitor vismodegib. Dr Siller told the limbic ...

Already a member?

Login to keep reading.

© 2021 the limbic